Eric Dobmeier - Dec 14, 2022 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC. (KDNY)

Role
President, CEO, Director
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Stock symbol
KDNY
Transactions as of
Dec 14, 2022
Transactions value $
$10,500
Form type
4
Date filed
12/15/2022, 03:27 PM
Previous filing
Dec 2, 2022
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KDNY Common Stock Options Exercise $10.5K +30K +12.41% $0.35* 272K Dec 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Stock Option (Right to Buy) Options Exercise $0 -30K -7.83% $0.00 353K Dec 14, 2022 Common Stock 30K $0.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vested as to 25% of the total shares on April 1, 2020, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.